Sales acceleration and robust margin expansion in Q3
12/08/19 -"Sales momentum accelerated significantly in Q3 led by broad-based growth across the ophthalmology segment, particularly in Asia. Growth in adjusted EBIT was even higher on the back of the increasing ..."
Pages
65
Language
English
Published on
12/08/19
You may also be interested by these reports :
10/05/24
While the 2023 EPS benefitted from material deferred tax income, we have moderated our earnings estimates for 2024-25 owing to high interest rates ...
10/05/24
Fresenius reported Q1 figures that exceeded the consensus, with revenues increasing by 0.3%, adjusted EBIT by 4.5%, net income from continuing ...
09/05/24
Smith & Nephew reported marginally softer than expected Q1 24 numbers. The weakness was largely attributable to US implants and areas within wound ...
08/05/24
CZM reported soft Q2 results with both sales and adjusted EBIT missing the street’s expectations. The mid-single-digit sales decline was due to ...